All the news Showing 5 of 65 articles from: Antiviral therapyGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Many people need hepatitis B treatment in the Gambia Liz Highleyman / 17 July 2013 About 8% of people tested through a community-based screening program in the Gambia have hepatitis B, and about 8% of these have advanced liver disease and meet European criteria for antiviral therapy, according ... Truvada works best for immune-tolerant hepatitis B patients, but do they need treatment? Liz Highleyman / 07 May 2013 A combination of tenofovir and emtricitabine (the drugs in the combination pill Truvada) suppressed hepatitis B virus (HBV) replication more than tenofovir alone over four years for people with inactive or immune-tolerant disease, ... HIV Drug Combo Shows Promise in Hepatitis B MedPage Today Gastroenterology / 28 April 2013 Nucleoside analogues reduce hepatitis B liver cancer risk Liz Highleyman / 29 November 2012 Treatment of chronic hepatitis B with nucleoside analogues including lamivudine (Epivir) and entecavir (Baraclude) can reduce the risk of developing hepatocellular carcinoma, including cancer recurrence after successful resection surgery, according to data presented ... Tenofovir safe and effective for long-term hepatitis B treatment with little bone loss Liz Highleyman / 22 November 2012 Tenofovir (Viread) continues to be safe and effective for treating chronic hepatitis B through eight years of follow-up, researchers reported at The Liver Meeting 2012, the 63rd Annual Meeting of the American Association ... ← Prev1...34567Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive